Posted in | News | Plastics and Polymers | Business

Eastman Chemical Sells PET Business of Performance Polymers to DAK Americas

Editorial Checklist Reviewed
Feb 2 2011

Eastman Chemical Company (NYSE:EMN) announced that it has completed the previously announced sale of its Performance Polymers segment’s PET business, related assets, and technology to DAK Americas, LLC.

The total cash proceeds of the transaction were $600 million, subject to post-closing adjustment for working capital. The company will recognize a modest gain from the sale in first quarter 2011.

The divestiture, which includes the company’s Performance Polymers segment assets at its Columbia, South Carolina site, will not impact product lines in the company’s Specialty Plastics segment.

Source:

http://www.eastman.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback